Urinalysis is a medical test that includes a physical, chemical, and microscopic examination of the urine. A urinalysis involves checking the appearance, concentration and content of urine. It is often done to check for kidney problems, urinary tract infections, and/or diabetes. Most commonly, this test is indicated when clinicians suspect an infection and to evaluate for the kidney and metabolic disorders. Urinalysis can also reveal diseases that have gone unnoticed because they do not produce striking signs/symptoms. Urinalysis is a safe and non-invasive test and thus, there is an increasing demand for urinalysis devices and solution across the globe.
Market Statistics:
The Global Urinalysis Market is estimated to account for US$ 1,712.0 Mn in terms of value by the end of 2023.
Drivers:
Increasing demand for urinalysis devices or solution owing to rising prevalence of chronic kidney diseases (CKD) is expected to drive growth of the global urinalysis market. Increasing prevalence of chronic kidney diseases worldwide has created a significant demand for urinalysis tests, as early detection of kidney dysfunction is crucial for effective management and to prevent the progression of renal disorders. According to the European Kidney Health Alliance (EKHA), around 75 million people suffer from chronic kidney disease (CKD) in Europe whereas the worldwide frequency has been estimated to 700 to 800 million people, with a projection that CKD will become the 5th cause of death globally in 2040; driving the growth of the market.
Opportunities:
Rising preference for point of care testing around the world is expected to offer significant growth opportunities for players in the global urinalysis market. Doctors may recommend at-home urine testing of luteinizing hormone (LH) as a quick and helpful way to track ovulation; testing a sample of urine to detect an increase in LH that occurs prior to ovulation. In April 2022, Mankind Pharma announced the launch of the rapid-testing pregnancy device that is used for urinalysis to confirm pregnancy. It is a single-step pregnancy test device that does not require the collection of urine in a dropper or container, making it the easiest and most convenient to test pregnancy at home. This in turn is driving the growth of the global urinalysis market.
Restraints:
Stringent regulatory framework or stringent rules and regulations are expected to hamper growth of the global urinalysis market. In the United States, diagnostic tests are regulated by the Food and Drug Administration (FDA), which means manufacturers must submit studies confirming a test’s accuracy and efficacy in diagnosing a particular condition before bringing it to market. Moreover, the process required for the new commercial test to gain approval for marketing can be costly and time-consuming, and may sometimes take up to years. Although FDA has a well-developed and structured framework, rules and regulations are essential and must be strictly followed.
COVID-19 Impact Analysis:
The outbreak of COVID-19 had a severe impact on the market, as hospitals and healthcare services around the world restricted urinalysis services due to social distancing measures enforced to curb the spread of the virus. For instance, according to article published in July 2021 in the International Journal of Surgery, urological procedures delayed or postponed during the COVID-19 pandemic. However, with the ease of restrictions and declining cases of COVID-19, the market is expected to witness robust growth during the forecast period.
Key Takeaways:
The global urinalysis market was valued at US$ 1,609.8 Mn in 2022 and is forecast to reach a value of US$ 2,669.2 Mn by 2030 at a CAGR of 6.5% between 2023 and 2030.
To know the latest trends and insights prevalent in this market, click the link below:
https://www.coherentmarketinsights.com/market-insight/urinalysis-market-382
Consumables segment held dominant position in the global urinalysis market in 2022, accounting for 68.1% share in terms of value, increasing approval and launch of new products is expected to propel growth of the segment during the forecast period.
Market Trends:
Technological advancements is one of the key trends expected to augment the growth of the global urinalysis market. Continuous technological advancements in urinalysis equipment and point-of-care (POC) testing devices have improved accuracy, speed, and ease of use, promoting the use or adoption of urinalysis tests across various healthcare settings. Technological advancements have also paved the way for significant progress in automated urinalysis. Each system uses a different technology to classify/quantify urine sediments and offers an improvement in standardization over manual microscopy by eliminating potential inter-technician variability during slide interpretation. This in turn is also expected to augment the growth of the market.
Competitive Landscape:
Major players operating in the global urinalysis market include Arkray Inc., Abbott Laboratories, Eiken Chemical Co. Ltd., Sysmex Corporation, Siemens Healthineers AG, Cardinal Health Inc., Acon Laboratories Inc., Bio-Rad Laboratories Inc., Becton, Dickinson & Company, F. Hoffmann-La Roche Ltd., and Danaher Corporation (Beckman Coulter Inc.), among others.
Recent Developments:
In September 2022, Sysmex Corp. announced the launch of the new UF-1500 fully automatic urine particle analysing tool for urine sediment testing, strengthening and expanding its product portfolio while maintaining its market position.
In July 2022, Arkray announced the launch of AUTION AI-4510, an innovative automated urine sediment analyzer with built-in capabilities to speed up operations and with on-board auto dilution that eliminates waste and ensures greater accuracy.
